DBV Technologies | DBVT - Ebitda





Ebitda Changement Date
Acadia Pharmaceuticals USD 20.31M 15.44M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amarin USD 12.54M 28.57M 2025-06
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
DBV Technologies USD -45.9M 12.42M 2026-03
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Galectin Therapeutics USD -7.42M 819K 2021-12
Halozyme Therapeutics USD 219.57M 197.66M 2026-03
Incyte USD 367.97M 46.53M 2026-03
Insmed USD -148.3M 165.88M 2026-03
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
PTC Therapeutics USD -70.99M 91.62M 2025-12
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
Ultragenyx Pharmaceutical USD -99.43M 57.35M 2025-12
United Therapeutics USD 379.5M 83.4M 2025-12